{"nctId":"NCT00231283","briefTitle":"NEXUS Study for the Treatment of de Novo Native Coronary Artery Lesions","startDateStruct":{"date":"2004-04"},"conditions":["Coronary Artery Disease"],"count":100,"armGroups":[{"label":"1","type":"EXPERIMENTAL","interventionNames":["Device: CYPHER NxT SES ON BX SONIC OTW STENT DELIVERY SYSTEM (SDS)"]}],"interventions":[{"name":"CYPHER NxT SES ON BX SONIC OTW STENT DELIVERY SYSTEM (SDS)","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Male or non-pregnant female patients 18 years of age\n2. Diagnosis of angina pectoris as defined by Canadian Cardiovascular Society Classification (CCS I, II, III, IV) OR unstable angina pectoris (Braunwald Classification B\\&C, I-II) OR patients with documented silent ischemia;\n3. Treatment of a single de novo target lesion in a major native coronary artery;\n4. Target lesion is 2.5 mm and 3.5 mm in diameter (visual estimate);\n5. Target lesion is 30mm in length (visual estimate);\n6. Target lesion stenosis is \\> 50% and \\< 100% (visual estimate);\n\nExclusion Criteria:\n\n1. Patient has experienced a Q-wave or non-Q-wave myocardial infarction with documented total CK \\> 2 times normal within the preceding 24 hours and the CK and CK-MB enzymes remain above normal at the time of treatment;\n2. Has unstable angina classified as Braunwald III B or C, or is having a peri-infarction angina;\n3. Significant (\\> 50%) stenoses proximal or distal to the target lesion that might require revascularization or impede runoff;\n4. Documented Left ventricular ejection fraction 25%;\n5. Totally occluded vessel (TIMI 0 level);\n6. Impaired renal function (creatinine \\> 3.0 mg/dl) at the time of treatment;","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Percentage of Participants Who Achieved Procedure Success From Post-procedure to Hospital Discharge","description":"Procedure Success is defined as the final residual diameter stenosis \\< 50 percent by Quantitative Coronary Angiography (QCA) using any percutaneous method, without the occurrence of death, Myocardial Infarction (MI), or repeat revascularization of the target lesion","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"97","spread":null}]}]}]},{"type":"SECONDARY","title":"Percentage of Participants Who Experienced Any Major Adverse Cardiac Events From Post-procedure to 30 Days Later","description":"Major Adverse Cardiac Events (MACE) consists of death, Myocardial Infarction (Q-wave and Non Q-wave), emergent Coronary Artery Bypass Graft (CABG) or Target Lesion Revascularization (TLR).","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.0","spread":null}]}]}]},{"type":"SECONDARY","title":"Percentage of Participants Who Experienced Any Major Adverse Cardiac Events From Post-procedure to Hospital Discharge","description":"Major Adverse Cardiac Events (MACE) consists of death, Myocardial Infarction (Q-wave and Non Q-wave), emergent Coronary Artery Bypass Graft (CABG) or Target Lesion Revascularization (TLR).","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.0","spread":null}]}]}]},{"type":"SECONDARY","title":"Percentage of Participants Who Experienced Any Major Adverse Cardiac Events From Post-procedure to 12 Months Later","description":"Major Adverse Cardiac Events (MACE) consists of death, Myocardial Infarction (Q-wave and Non Q-wave), emergent Coronary Artery Bypass Graft (CABG) or Target Lesion Revascularization (TLR).","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10.4","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":1,"n":95},"commonTop":["Target Vessel Failure","Target Vessel Revascularization","Target Lesion Revascularization","Myocardial Infarction (Q wave or Non-Q wave)","Emergent CABG"]}}}